Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):36–39. doi: 10.1097/QAI.0000000000001879

Table 2:

PrEP awareness among all women and women meeting CDC indications for PrEP

All cisgender women
(N=1431)
Cisgender women
meeting CDC
indications for PrEP
(N=84)

n % AOR 95% CI n %
Year
 2013 32 13.9 Ref 1 5.9
 2014 63 17.8 1.34 0.84 to 2.15 7 25.0
 2015 64 16.0 1.18 0.74 to 1.88 5 26.3
 2016 77 17.3 1.31 0.83 to 2.07 6 30.0
Race/Ethnicity
 Non-Hispanic White 127 20.7 Ref 11 22.5
 Non-Hispanic Black 33 13.8 0.59 0.39 – 0.89 1 *
 Hispanic/Latino 42 11.0 0.46 0.31 – 0.66 2 10.5
 Other/Unknown 34 17.3 0.78 0.51 – 1.19 5 41.7
Age group
 18–24 103 15.3 Ref 5 21.7
 25–34 94 20.4 1.38 1.01 – 1.88 5 19.2
 35–54 35 13.4 0.79 0.52 – 1.20 9 28.1
 55+ 4 11.1 0.59 0.21 – 1.67 0 *

PrEP – pre-exposure prophylaxis; CDC – Centers for Disease Control and Prevention; AOR – adjusted odds ratio; CI – confidence interval

*

Not reported because of a sample size of fewer than 10 people. We did not evaluate PrEP awareness by demographic characteristics among women with CDC indications for PrEP due to the small sample size.